Atrial Fibrillation, Ventricular Arrhythmias
Conditions
Brief summary
The investigators study aimed to observe the occurrence of new premature ventricular complexes and other ventricular arrhythmias after pulmonary vein isolation.
Detailed description
Atrial fibrillation is the most common arrhythmia with a lifetime risk for development of over 20%. Pulmonary vein isolation is now established as therapy of choice for patients with symptomatic atrial fibrillation. It is well known that this interventional therapy inevitably modulates the intracardiac autonomic nervous system. While this ablation might alter atrial electrophysiology beneficially, the impact on ventricular electrophysiology remains unclear.
Interventions
None listed
Sponsors
Study design
Eligibility
Inclusion criteria
* Age \> 18 years * Paroxysmal atrial fibrillation scheduled to undergo pulmonary vein isolation
Exclusion criteria
* Age \< 18 years * Persistent atrial fibrillation * Life expectancy less than 12 months * Acute myocardial infarction, coronary artery bypass graft surgery, open heart surgery, or percutaneous transluminal coronary angioplasty within less than 3 months prior to inclusion * Documentation of \>30 premature ventricular complexes per hour, salvos or ventricular tachycardias prior to atrial fibrillation ablation
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Ventricular arrhythmias | one year | Number of patients with premature ventricular complexes, ventricular tachycardias or ventricular fibrillation. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Arrhythmia recurrence | one year | Number of patients with premature ventricular complexes, ventricular tachycardias or ventricular fibrillation. |
Countries
Germany